Switch to:

Regulus Therapeutics Inc (RGLS)Ownership Data

Short Interest History (%)

This is the historical short interest of Regulus Therapeutics Inc, as measured by the Short Percentage Of Float.

Date Short Interest
February 13, 201513.23
January 30, 201554.27
January 15, 201550.65
December 31, 201450.93
December 15, 201440.61
November 28, 201438.13
November 14, 201441.33
October 31, 201438.55
October 15, 201410.92
September 30, 201411.02
September 15, 201410.08
August 29, 20149.75
August 15, 20149.65
July 31, 20149.74
July 15, 20149.46
June 30, 20149.1
June 13, 20149.24
May 30, 20149.57
May 15, 20149.77
April 30, 20149.18
April 15, 20149.88
March 31, 201411.8
March 14, 201411.96
February 28, 201415
February 14, 201417.25
January 31, 201414.99
January 15, 201410.05
December 31, 20138.57
December 13, 20137.07
November 29, 20137.57
November 15, 20139.49
October 31, 201311.76
October 15, 201314.25
September 30, 201313.21
September 13, 201313.42
August 30, 201312.58
August 15, 201311.7
July 31, 20136.87
July 15, 20133.32
June 28, 20134.4
June 14, 20133.54
May 31, 20133.28
May 15, 20133.4
April 30, 20133.7
April 15, 20132.92
March 28, 20132.42
March 15, 20132.38
February 28, 20132.37
February 15, 20132.6
January 31, 20132.41
January 15, 20132.42
December 31, 20122.83
December 14, 20120.02
November 30, 20120.01
November 15, 20120.01
October 31, 20120.02
October 15, 20120.01

Institutional Ownership History (%)

This the Institutional Ownership History of Regulus Therapeutics IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
December 31, 201490
November 30, 201492
September 30, 201494
August 31, 201495
July 31, 201495
February 28, 201495
January 31, 201499
November 30, 201398
October 31, 201397
September 30, 201386
August 31, 201386
July 31, 201386
June 30, 201392
May 31, 201395
April 30, 201395
March 31, 201339
February 28, 201339
January 31, 201339
December 31, 20124
November 30, 20123
October 31, 20122

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Stelios Papadopoulos,PhDN/A150,0000.31%2014-12-12
Dr. Kleanthis G. Xanthopoulos,PhDPresident and CEO2,466less than 0.1%2015-01-30

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Fidelity Management and Research Company7,290,5742015-02-1314.430.00139,614,492
Alnylam Pharmaceuticals Inc5,896,7162014-12-3112.050.0094,583,325
Isis Pharmaceuticals Inc5,516,3052014-11-0311.350.00110,105,448
Sanofi5,053,7792014-02-0711.710.0045,989,389
RA Capital Management, LLC4,742,9112014-12-319.698.0576,076,000
AstraZeneca PLC4,250,0002014-12-318.680.0068,170,000
Wellington Management Company LLP3,779,1742014-12-317.720.0260,618,000
Fidelity® Growth Company Fund3,281,5702015-01-316.700.1562,842,066
Capital World Investors2,281,7282014-12-314.660.0136,599,000
GlaxoSmithKline PLC1,947,0372014-02-074.510.0017,718,037

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK